Divalproex Sodium ER Tablets USP, 250 mg and 500 mg, is the generic equivalent of Depakote ExtendedRelease (ER) Tablets, 250 mg and 500 mg, of AbbVie Inc., indicated for:
Acute treatment of manic or mixed episodes associated with bipolar disorder, with or without psychotic features
Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures
Prophylaxis of migraine headaches
Divalproex Sodium Extended-Release (ER) Tablets USP (RLD: Depakote ER) had annual sales of approximately USD 130 million in the U.S. (IQVIA MAT July 2020).
Powered by Capital Market - Live News